The Chief Executive of Swisse Wellness, Radek Sali, has resigned from the company he has headed for the past nine years, after he and other minority shareholders sold their stake to Biostime International. Sali stepped down on December 31 as the Hong Kong company took control. Swisse’s Managing Director, Adem Karafili has also resigned.
Biostime bought a majority stake in Swisse in September and the latest transaction gives it full ownership of the Melbourne-based company. Biostime Chief Executive and Chairman Luo Fei said the Swisse brand is renowned for its innovation, quality, and premium positioning, and Sali had a big part in building its reputation.
“Under Radek’s dedicated leadership, Swisse Wellness has achieved significant year-on-year revenue growth and has been lauded as one of the fastest growing in the category globally over the last 10 years,” he said.
Swisse will now focus increasing its reach via new channels in China including e-commerce, pharmacies and supermarkets, and expand into the US and other countries in Europe during 2017.
Oliver Horn, formerly of Treasury Wines Estates, has been appointed as the new Managing Director.
